Skip to main content
Log in

Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer

  • Brief Communication
  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

Background

Quality of Life Core Questionnaire of the European Organization for the Research and Treatment of Cancer (EORTC QLQ-C30) is one of the most used quality of life questionnaires in cancer studies. It provides scores for five functional scales, nine symptom scales, and two single items which assess overall health status and quality of life. However, high correlations among QLQ-C30 items suggest a reduced dimensionality for the scale.

Objective

To assess the dimensionality of the EORTC QLQ-C30 using item response theory (IRT) in a training sample and confirmatory factor analysis (CFA) in a test sample.

Methods

We analyzed responses to QLQ-C30 from 1,107 patients with advanced lung cancer who were included in five clinical trials of immunotherapy. We used non-parametric and parametric IRT models (Mokken, and Samejima's graded response) in a random training set (n = 332) for initial assessment of dimensions and item characteristics of the QLQ-C30. Finally, we used CFA in the test set (n = 775) to confirm the measurement domains.

Results

Mokken model showed that QLQ-C30 fits a unidimensional scale, whereas Samejima model showed that most QLQ-C30 items present adequate difficulty and discrimination. All items showed adequate scalability indexes with an overall scalability of 0.47 (medium scale). The QLQ-C30-reduced dimensionality was confirmed by CFA (comparative fit index = 0.98, root mean square error of approximation = 0.055) with all items presenting factorial loadings > 0.40.

Conclusions

The EORTC QLQ-C30 fits a unidimensional latent construct identified with perceived quality of life in advanced lung cancer patients.

Trial registration

RPCEC00000161, RPCEC00000181 and RPCEC00000205

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Abbreviations

EORTC QLQ-C30:

Quality of life core questionnaire of the European Organization for the Research and Treatment of Cancer

IRT:

Item response theory

CFA:

Confirmatory factor analysis

QoL:

Quality of life

NSCLC:

Non-small-cell lung cancer

CECMED:

Cuban regulatory agency for drugs

MHM:

Monotone homogeneity model

DMM:

Double monotonicity model

ICC:

Item characteristic curve

CFI:

Comparative fit index

RMSEA:

Root mean square error approximation

GRM:

Graded response model

LRT:

Likelihood ratio test

References

  1. Braun, D. P., Gupta, D., & Staren, E. D. (2011). Quality of life assessment as a predictor of survival in non-small cell lung cancer. BMC Cancer, 11(1), 353.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Gupta, D., Braun, D. P., & Staren, E. D. (2012). Association between changes in quality of life scores and survival in non-small cell lung cancer patients. European Journal Cancer Care, 21(5), 614–622.

    Article  CAS  Google Scholar 

  3. Li, T.-C., Li, C.-I., Tseng, C.-H., et al. (2012). Quality of life predicts survival in patients with non-small cell lung cancer. BMC Public Health, 12(1), 1–1.

    Article  Google Scholar 

  4. Ediebah, D. E., Coens, C., Zikos, E., et al. (2014). Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. British Journal of Cancer, 110(10), 2427–2433.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Damm, K., Roeske, N., & Jacob, C. (2013). Health-related quality of life questionnaires in lung cancer trials: a systematic literature review. Health Economics Review, 3(1), 1–1.

    Article  Google Scholar 

  6. Bouazza, Y. B., Chiairi, I., El Kharbouchi, O., et al. (2017). Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review. Lung Cancer, 113, 140–151.

    Article  PubMed  Google Scholar 

  7. Fayers, P., & Bottomley, A. (2002). Quality of life research within the EORTC—the EORTC QLQ-C30. European Journal of Cancer, 38, 125–133.

    Article  Google Scholar 

  8. Cocks, K., King, M. T., Velikova, G., et al. (2011). Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. Journal of Clinical Oncology, 29(1), 89–96.

    Article  PubMed  Google Scholar 

  9. Aaronson, N. K., Ahmedzai, S., Bergman, B., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.

    Article  CAS  PubMed  Google Scholar 

  10. Nicklasson, M., & Bergman, B. (2007). Validity, reliability and clinical relevance of EORTC QLQ-C30 and LC13 in patients with chest malignancies in a palliative setting. Quality of Life Research, 16(6), 1019–1028.

    Article  PubMed  Google Scholar 

  11. Costa, D. S. J., Aaronson, N. K., Fayers, P. M., et al. (2014). Testing the measurement invariance of the EORTC QLQ-C30 across primary cancer sites using multi-group confirmatory factor analysis. Quality of Life Research, 24(1), 125–133.

    Article  PubMed  Google Scholar 

  12. Osoba, D., Zee, B., Pater, J., et al. (1994). Psychometric properties and responsiveness of the EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Quality of Life Research, 3(5), 353–364.

    Article  CAS  PubMed  Google Scholar 

  13. Cocks, K., King, M. T., Velikova, G., et al. (2012). Evidence-based guidelines for interpreting change scores for the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. European Journal of Cancer, 48(11), 1713–1721.

    Article  CAS  PubMed  Google Scholar 

  14. Bedard, G., Zeng, L., Zhang, L., et al. (2013). Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer. Asia-Pac Journal of Clinical Oncology, 10(2), 109–117.

    Article  Google Scholar 

  15. Maringwa, J. T., Quinten, C., King, M., et al. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753–1760.

    Article  PubMed  Google Scholar 

  16. Fayers, P. M., Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. (2001). EORTC QLQ-C30 Scoring Manual (3rd ed.). Brussels: European Organisation for Research and Treatment of Cancer.

    Google Scholar 

  17. Shih, C.-L., Chen, C.-H., Sheu, C.-F., Lang, H.-C., & Hsieh, C.-L. (2013). Validating and Improving the Reliability of the EORTC QLQ-C30 Using a Multidimensional Rasch Model. Value Health, 16(5), 848–854.

    Article  PubMed  Google Scholar 

  18. van der Kloot, W. A., Kobayashi, K., Yamaoka, K., et al. (2014). Summarizing the fifteen scales of the EORTC QLQ-C30 Questionnaire by five aggregate scales with two underlying dimensions: A literature review and an empirical study. Journal of psychosocial oncology, 32(4), 413–430.

    Article  PubMed  Google Scholar 

  19. Gundy, C. M., Fayers, P. M., Groenvold, M., et al. (2011). Comparing higher order models for the EORTC QLQ-C30. Quality of Life Research, 21(9), 1607–1617.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Giesinger, J. M., Kieffer, J. M., Fayers, P. M., et al. (2016). Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. Journal of Clinical Epidemiology, 69, 79–88.

    Article  PubMed  Google Scholar 

  21. Vinageras, E. N., de la Torre, A., Rodríguez, M. O., et al. (2008). Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non–small-cell lung cancer. Journal of Clinical Oncology, 26(9), 1452–1458.

    Article  CAS  Google Scholar 

  22. Rodriguez, P. C., Popa, X., Martinez, O., et al. (2016). A Phase III clinical trial of the epidermal growth factor vaccine CIMAvax-EGF as switch maintenance therapy in advanced non-small cell lung cancer patients. Clinical Cancer Research, 22(15), 3782–3790.

    Article  CAS  PubMed  Google Scholar 

  23. Hernandez, M., Ortiz, R. A., Neninger, E., et al. (2016). P2.40: CIMAvaxEGF vaccine for the treatment of real-world NSCLC patients. Journal of Thoracic Oncology, 11(10), S242.

    Article  Google Scholar 

  24. Molenaar I. W. (1997) Nonparametric models for polytomous responses. In: W. J. van der Linden., R. K. Hambleton (Eds.), Handbook of modern item response theory (pp. 369–380). New York, NY: Springer New York.

    Chapter  Google Scholar 

  25. Mokken R. J. (1997) Nonparametric models for dichotomous responses. In: W. J. van der Linden., R. K. Hambleton (Eds.), Handbook of modern item response theory (pp. 351–367). New York, NY: Springer New York.

    Chapter  Google Scholar 

  26. Brown, T. A. (2006). Confirmatory factor analysis for applied research. New York: The Guilford Press.

    Google Scholar 

  27. Team RC (2013) R: a language and environment for statistical computing. https://www.R-project.org/.

  28. Ark, L. A. V. D. (2007). Mokken Scale Analysis in R. Journal of Statistical Software. https://doi.org/10.18637/JSS.V020.I11.

    Article  Google Scholar 

  29. Ark, L. A. V. D. (2012). New developments in Mokken scale analysis in R. Journal of Statistical Software. https://doi.org/10.18637/jss.v048.i05.

    Article  Google Scholar 

  30. Rizopoulos, D. (2006). ltm: An RPackage for latent variable modeling and item response theory analyses. Journal of Statistical Software, 17(5), 1–25.

    Article  Google Scholar 

  31. Rosseel, Y. (2012). lavaan: An RPackage for structural equation modeling. Journal of Statistical Software, 48(2), 1–36.

    Article  Google Scholar 

  32. Petersen, M. A., Groenvold, M., Aaronson, N., et al. (2006). Item response theory was used to shorten EORTC QLQ-C30 scales for use in palliative care. Journal of Clinical Epidemiology, 59(1), 36–44.

    Article  PubMed  Google Scholar 

  33. Arraras, J. I., Suárez, J., Arias de la Vega, F., et al. (2011). The EORTC quality of life questionnaire for patients with colorectal cancer: EORTC QLQ-CR29 validation study for Spanish patients. Clinical and Translational Oncology, 13(1), 50–56.

    Article  PubMed  Google Scholar 

  34. Arraras Urdaniz, J. I., Villafranca Iturre, E., Arias de la Vega, F., et al. (2008). The EORTC quality of life questionnaire QLQ-C30 (version 3.0). Validation study for Spanish prostate cancer patients. Archivos Espanoles de Urologia, 61(8), 949–954.

    PubMed  Google Scholar 

  35. Scott, N. W., Fayers, P. M., Bottomley, A., et al. (2006). Comparing translations of the EORTC QLQ-C30 using differential item functioning analyses. Quality of Life Research, 15(6), 1103–1115.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the EORTC for authorizing us to use the QLQ-C30 questionnaires in patients with non-small cell lung cancer.

Funding

Funding for the analyses of this study was provided by a Union for International Cancer Control (UICC) Technical Fellowship Award UICC-TF/17/545061 to Carmen Viada. Javier Ballesteros is supported by UPV/EHU research groups grant (GIU14/27).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Carmen Viada.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 12 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Viada, C., Bouza, C., Fors, M. et al. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer. Qual Life Res 29, 3441–3448 (2020). https://doi.org/10.1007/s11136-020-02584-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11136-020-02584-5

Keywords

Navigation